Seer Inc (SEER) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Seer (NASDAQ:SEER) Is In A Good Position To Deliver On Growth Plans
Yahoo FinanceDec 21 07:39 ET
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500
Seer IncNov 21 00:00 ET
Mixed Financial Results and Strategic Partnerships Lead to Hold Rating for Seer Inc.
TipRanksNov 18 05:12 ET · Ratings
Seer to Participate in Upcoming November Investor Conferences
GlobeNewswireNov 8 07:00 ET
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating
Moomoo NewsNov 6 22:31 ET · Ratings
Seer, Inc. (SEER) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsNov 6 21:00 ET

Comments

Jaguar8

Oct 31 06:08

NEWS

$Seer Inc (SEER.US)$
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
Seer will showcase its Proteograph Product Suite at the American Society of Human Genetics (ASHG) 2024 Annual Meeting, demonstrating how deep proteomics enhances genomic research. The company will present breakthrough research in lung cancer and Alzheimer's Disease through a CoLab session featuring PrognomiQ and Salk Institute.
Key highlights incl...

1

Jaguar8

Jun 11 12:48

NEWS

$Seer Inc (SEER.US)$
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
Seer has published three papers demonstrating its Proteograph Product Suite's ability to uncover novel plasma proteomic insights during spaceflight. Data from the SpaceX Inspiration4 mission revealed acute changes in oxidative stress, brain homeostasis, and coagulation, with many alterations persisting six months post-flight. Seer’s tech...

2

Jaguar8

Jun 2 10:39

NEWS

$Seer Inc (SEER.US)$
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Seer has announced the completion of a groundbreaking mass spectrometry study by PrognomiQ, utilizing Seer's Proteograph Product Suite and the Thermo Scientific Orbitrap Astral mass spectrometer. This multi-cancer case-control study involved 2,840 subjects and identified over 13,000 protein groups, with an average of 8,200 protein groups per sample...

Moomoo AI

Nov 17, 2023 04:35

While Seer is forecasted to have more rapid revenue growth than the wider market, the stark decrease in revenue estimates might cause investors to be more cautious about the company.

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

Moomoo Breakfast US

Aug 10, 2022 07:45

Columns Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more

Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%,...

11

3

5

SEER Seer Inc

Trade Overview

Capital Trend

News

Comments